Blue

With compelling narratives and expert insights, Pao’s book "Breakthrough: The Quest for Life-Changing Medicines" offers readers a rare glimpse into the intersection of science, perseverance, and human impact.

New Book Chronicles Journey Behind Life-Saving Medicines

Insilico Medicine is revolutionizing drug discovery for mesothelioma and other solid tumors with its generative AI engine .

Insilico Inks Exclusive License for Anti-Cancer Molecule

Shalabh Gupta, MD, CEO and founder of Unicycive Therapeutics, is on a mission to revolutionize kidney disease care by changing drug formulation to address the overwhelming number of daily pills patients must take.

How can Nanoparticles Transform Kidney Disease Care

Angel investor and pharma industry executive-turned-consultant Shwen Gwee has worked with startups for more than 15 years, garnering insights for biopharma entrepreneurs.

5 Startup Funding Tips from Angel Investor Shwen Gwee

Evommune, Inc., a clinical-stage biotech and Cure Collaboration Residency company, secured $115 million in Series C financing, underscoring its pioneering approach to developing novel therapies for chronic inflammatory diseases.

Evommune $115M Series C Funding Fuels Innovation in Chronic Inflammation

Insilico Medicine reports its investigational SM001-055 - the first drug designed using generative AI - had encouraging topline results in a phase 2A clinical trial.

First AI-Designed Drug Improves IPF Lung Function

Metallomix combines biochemistry and biophysics to leverage the body’s "metallome," and its broader molecular networks and other "omes" — such as the genome, proteome and microbiome.

Metallomix: The Biotech Transforming Disease with Metal-Based Therapies

Kristen Dahlgren, Founder and CEO of the Cancer Vaccine Coalition, discusses groundbreaking efforts to speed cancer vaccines, starting with breast cancer. 

How the Cancer Vaccine Coalition Pushes Life-Saving Science Forward

Evommune, led by CEO Luis Peña, is on a mission of tackle one of the world’s leading root cause of deaths: chronic inflammation, which is linked to more than 100 autoimmune diseases.

thumb_luis_pena_evommune

How Evommune is Redefining Treatments for Chronic Inflammatory and Autoimmune Diseases

The FDA recently announced a newRare Disease Innovation Hub, designed to expedite development and approval of new treatments for patients with rare diseases. Cure Xchange Challenge winner Every Cure weighs in.

Every Cure’s Grant Mitchell on Hopes and Challenges for the FDA’s New Rare Disease Hub

Elemento leads efforts to tailor treatments for individual patients’ diseases by deciphering their molecular roots with cutting-edge technologies.

thumbnail_olivier_elemento

Olivier Elemento’s Vision for Mainstreaming Precision Medicine

Most biomedical researchers agree that the promise of AI for the future drug discovery is likely to be extraordinary. What can we expect in the  next decade?

thumbnail_five_ways_AI_influence_drug_discovery

Five Ways AI May Influence the Future of Drug Discovery

In the world of drug discovery, AI engenders feelings of hope, excitement and optimism. Indeed, machine learning algorithms already accelerate discovery, improve efficiency, reduce costs and even save lives.

NYAS

Inspiring Hope, Not Fear:  How AI is Already Transforming Drug Discovery

Explore the candid opinions of endocrinologists on GLP-1 drugs like Ozempic and Mounjaro. Uncover their thoughts on efficacy, patient satisfaction and the future landscape of these groundbreaking treatments in our white paper.

White Paper GLP-1

What Doctors Really Think of GLP-1 Medications

sascha_haubner_headshot_article_background

Leveraging CAR T Therapy to Tackle Acute Myeloid Leukemia

Sickle Cells

The Promises and Perils of Gene Editing for Sickle Cell

#moonshot conveys a seeming impossible challenge that requires disruptive, innovative thinking and the right mix of resources, talent and effort. Cure asked four healthcare thought leaders recently about their moonshots and what drives them to pursue these goals.


image_moonshot

What's Your Health Moonshot?

image women health menopause

Menopause Treatment: Delay and Disappointment

DNA Profile

3 Changes Genomics Microscopes Bring to Understanding Disease

Cure® Unveils US Biotech Industry Benchmark Report 2024: Dark Days of 2023 are Over

Computer Screens with DNA

From Clinic to Climate: Insilico’s Alex Zhavoronkov Talks AI

ALS Woman in Wheelchair -- AS 518531569

What’s in a ‘Cure’ for ALS? 

Industrial Molecular Revolution

What is the Molecular Industrial Revolution?

Your Baby's Genome: The Radical Promise of Early DNA Testing AS383185424

A Harvard Medical School Expert on Why We Should Sequence All Babies’ Genomes

Laurie Glimcher

What Needs to Happen to Accelerate Cancer Research and Improve Care?

Mary Woolley

What Will It Take to Maintain America’s Leadership in Research and Technology?

Cure® Opens XSeed Award Applications to Support Underfunded and Underrepresented NYC Life Science Startups With Up to $500,000

How Life Science Companies Use AI to Target Investors

Investing in AI for Drug Discovery: Capital, Data and Safety

 Genetic engineering of dinosaurs isn't possible, yet the technology has yielded cancer therapies and just might help us travel in outer space. 

The Case for (and Against) Genetic Engineering

Compared to life-threatening conditions like cancer, inflammatory and immune system diseases are understudied, yet they diseases are common and seriously affect patients' quality of life. Gregory S. Moss, Esq., Chief Corporate Strategy and Legal Officer at Evommune, a company advancing therapies for chronic inflammatory diseases, shares his insights.

Drug Development for Inflammatory Diseases Comes of Age

Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.  

Spotlight On_Grant_Mitchell_Image

Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure

Microsoft Chief Medical Officer David Rhew, MD, gets beyond the hype on the value of generative artificial intelligence (AI)  in healthcare today.

From Administrative Tasks to Drug Discovery, AI is Poised to Transform Healthcare

Cure® to Host “Moonshots and More,” A Fireside Chat with President and CEO of Dana-Farber Cancer Institute, Laurie H. Glimcher, MD

Insights

Michael Montello, MBA, discusses NASA, AI and pharma’s transition to using big data and modeling to boost the probability of success of new medicines and vaccines.

Cure Tuesday Talks banner image Michael Montello

How GSK is Powering R&D with Data, Digital and Tech

Cure CEO Seema Kumar sits down with Alex Zhavoronkov, PhD, Chairman and CEO of Insilico Medicine, discussing how generative AI is transforming and accelerating drug discovery.

Cure Tuesday Talks Alex Zhavoronkov banner image

Learning AI for Every Step of Pharma R&D

Vishal Mehta, MSHS, an expert pharmaceutical innovator, explains how his company speeds one of the most complex and costly enterprises in the life sciences – testing a candidate drug in people.

Cure Tuesday Talks Streamlining Critical Trials header image

Streamlining Clinical Trials 

Join Seema Kumar, CEO of Cure and Michael Foley, CEO of Deerfield Discovery & Development, for an evening of groundbreaking keynotes by two leading scientists: Bartosz Grzybowski, PhD, and Marty Burke, PhD. These two luminaries are applying AI, advanced synthetic chemistry, and decades of accumulated knowledge of functional molecules to advance the field of small molecule chemistry. They will discuss applications of their work in case studies that demonstrate the power of innovation in the fields of drug discovery, global chemical production, and national (bio)chemical security.

Welcome to the Molecular Industrial Revolution

Join Seema Kumar, the CEO of Cure, for an exclusive live announcement of the winners of the Cure Xchange Challenge: Health AI For Good, which is being held in partnership with the Clinton Foundation. John Mattison, MD, will provide a short keynote talk on the latest developments in AI in science, before Chelsea Clinton, DPhil, presents the awards to the winners. The Xchange Challenge winners will also present summaries of their companies and projects during the event.


Special Award Presenter: Chelsea Clinton DPhil, MPH, Clinton Foundation
Keynote: John Mattison, MD, Assistant Medical Director and Chief Medical Information Officer at Kaiser Permanente

Cure XChange Challenge Winner Announcement

Events

Become a member of Cure and help shape the future of healthcare.

Join our community

Regular

345 Park Avenue South

Xchange Challenge

All floors are lab-ready and cabled for digital health.

Community

Residents

Leadership

Be part of *Cure.*

Orange

Where scientists, entrepreneurs and visionaries converge.

Campus

Ecosystem

Event Spaces

Gallery

Space Availability

A place to *Succeed.*

Green

Joe Wilson How Life Sciences Companies Use AI to Target Investors Mega Menu Image 

Critical Discussions Advancing Healthcare

Upcoming Events

Event Inquiry

Past Events

Speakers

Tuesday Talks

Cure *Events.*

Magenta

Cure Clips

Tuesday Talks Series

Cure *Tuesday Talks*

Two awards up to $250,000

Partnerships and Sponsorships

Women in Science

XSeed Award

Connect with *Opportunity.*

Network

Cure Insights Article A Bionic Pancreas that will Help Parents Sleep More Peacefully image for Cure Insights Mega Menu.  Image credit Cottonbro Studio.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

Therapeutics

Insights

Events

Recommended Topics

Join our community

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

Therapeutics

Insights

Events

Recommended Topics

Join our community

Cure Events.

Cure Tuesday Talks

In-depth Insights.